Breaking News Bar

Business News and Information

COVID-19 Respiratory Monitoring with MediPines AGM100® in Long-Term Care Facilities

ORANGE COUNTY, Calif., Oct. 22, 2020 /PRNewswire/ -- Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a respiratory medical device company, has released a scientific paper on respiratory monitoring in long-term care facilities.

The CDC recommends frequent respiratory monitoring of long-term care residents, who are disproportionally impacted by COVID-19. The use of a portable, non-invasive respiratory monitoring system that detects pulmonary gas exchange impairment, like the MediPines AGM100®, is proving valuable in monitoring the elderly and those who are high-risk.

"We were concerned about the practicality of frequent respiratory monitoring in our elderly residents, and the presence of unpredictable conditions like silent hypoxemia. As a result, we committed to using an advanced respiratory monitoring system [AGM100] to obtain residents' gas exchange measurements. We are monitoring both residents and staff to establish a baseline respiratory measurement. By doing this we will recognize if there is any change in a resident's or staff's respiratory status, giving us an early indication of potentially harmful respiratory conditions (e.g., Covid)," stated Jon Howell, Co-Owner of Gracious Living Estates in Pennsylvania.

"Unfortunately, respiratory illnesses like COVID-19, are disproportionally impacting our elderly population. There is an urgent need for frequent respiratory monitoring in this at-risk population," said Steve Lee, CEO of MediPines. 

In an effort to support long-term care residents and workers, MediPines has released a scientific paper outlining the medical rationale behind proper respiratory monitoring. The discussion outlines the use of a non-invasive respiratory assessment for residents who may not be exhibiting classical symptoms (i.e. low oxygen saturation), but still may be suffering from lung damage due to COVID-19, such as "silent hypoxemia." The MediPines AGM100® is a respiratory monitoring system that provides rapid non-invasive pulmonary gas exchange measurements, typically in under two minutes.

See MediPines Scientific Series: "The Case for Respiratory Monitoring in Long-Term Care Facilities: COVID-19"

MediPines AGM100®  
MediPines AGM100® is an advanced respiratory monitoring system that provides a comprehensive respiratory assessment designed to support medical providers with rapid detection of respiratory impairment. MediPines AGM100® is an FDA cleared technology that non-invasively provides medical grade pulmonary gas exchange measurements. The device has been clinically validated and is FDA cleared and authorized for COVID-19 emergency use by Health Canada.

About MediPines
MediPines Corporation is a market leader in respiratory assessment and monitoring of pulmonary gas exchange.  Our mission is to advance respiratory medicine by providing physiology-based, respiratory devices that empower healthcare providers to advance the effectiveness and operating efficiency of patient care.   

To learn more about MediPines visit: medipines.com

Contact MediPines:
Carissa Drews
(949) 398-4670
info@medipines.com 

MediPines, in Orange County, California, is a medical device manufacturer that focuses on respiratory diagnostics and therapeutic management solutions. MediPines provides medtech solutions for respiratory screening, diagnostics, and management. (PRNewsfoto/MediPines)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/covid-19-respiratory-monitoring-with-medipines-agm100-in-long-term-care-facilities-301157596.html

SOURCE MediPines

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear